June 1, 2026

Labcorp Holdings Inc. (LH) Stock Analysis: Unlocking 19.25% Potential Upside in the Healthcare Sector

For investors keen on the healthcare sector, Labcorp Holdings Inc. (NYSE: LH) presents an intriguing opportunity. With a market capitalization of $21.32 billion, Labcorp stands as a significant player in..

Moderna, Inc. (MRNA) Stock Analysis: Evaluating a Biotech Powerhouse with a -8.46% Potential Downside

Moderna, Inc. (NASDAQ: MRNA), a leading player in the biotechnology sector, has captured investor attention with its innovative approach to messenger RNA (mRNA) medicines. Based in Cambridge, Massachusetts, Moderna has..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential in a Challenging Market

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is an integrated pharmaceutical company with a strong presence in North America, Europe, India, Russia, and other..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 40.95% Potential Upside for Investors

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, presents an intriguing opportunity for investors eyeing the medical instruments and supplies industry. With a market capitalization of $7.39..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with 8.7% Potential Upside

Revvity, Inc. (NYSE: RVTY), formerly known as PerkinElmer, Inc., is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.66..

BeOne Medicines Ltd. (ONC) Investor Outlook: Why a 42.93% Upside is Capturing Attention

Investors eyeing the biotechnology sector should take a close look at BeOne Medicines Ltd. (ONC), a Swiss-based oncology powerhouse with a robust focus on innovating cancer therapeutics. Despite a slight..

Novo Nordisk A/S (NVO) Stock Analysis: A Strong Performer with a Resilient 71.4% ROE

Investors have their eyes on Novo Nordisk A/S (NYSE: NVO), a formidable player in the healthcare sector, particularly within the drug manufacturing industry. With a robust market capitalization of $201.95..

STERIS plc (STE) Stock Analysis: Exploring a 20.74% Upside Potential in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents a compelling case. With a strong market presence in infection prevention products and services, STERIS operates across..

McKesson Corporation (MCK) Stock Analysis: Unpacking a 27.92% Potential Upside Amidst Strong Buy Ratings

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, has captured investor attention with its robust market presence and promising growth potential. With a market capitalization of $89.24 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unveiling 25.84% Potential Upside in the Diagnostics Market

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a formidable player in the healthcare sector, is making waves in the diagnostics and research industry. Headquartered in Westbrook, Maine, IDEXX continues to demonstrate robust..

Tenet Healthcare Corp (THC) Stock Analysis: A 39.5% Upside Potential Amidst Robust Analyst Ratings

Investors with an eye on the healthcare sector might find Tenet Healthcare Corporation (NYSE: THC) an intriguing opportunity. With a market capitalization of $15.1 billion, this U.S.-based healthcare services giant..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 25% Upside Potential Amid Strong Analyst Ratings

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, is attracting investor attention with promising growth metrics and a robust analyst consensus. Based in Durham, North Carolina,..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Challenges with Strategic Opportunities

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, is a company that has been providing managed healthcare services to low-income families and individuals under Medicaid..

Medtronic plc (MDT) Investor Outlook: Exploring a 44% Potential Upside in the Healthcare Giant

Medtronic plc (NYSE: MDT), a titan in the healthcare sector, is capturing investor attention with its promising potential upside of 44.37%. Based in Ireland, Medtronic is a global leader in..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Assessing a 24.17% Potential Upside and Strong Market Position

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a robust market capitalization of $183.03 billion,..

Intuitive Surgical, Inc. (ISRG) Investor Outlook: Exploring a 33.71% Potential Upside with Strong Revenue Growth

Investors with an eye on healthcare innovations and robotic-assisted surgical systems will find Intuitive Surgical, Inc. (NASDAQ: ISRG) an intriguing prospect. With a market capitalization of $150.39 billion, Intuitive Surgical..

The Cooper Companies, Inc. (COO) Stock Analysis: Can a 45% Potential Upside Justify Investor Interest?

The Cooper Companies, Inc. (NYSE: COO) stands out in the healthcare sector, primarily through its strong presence in the medical instruments and supplies industry. With a robust market capitalization of..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Exploring a 16.85% Upside Potential

Teva Pharmaceutical Industries (NYSE: TEVA) is a heavyweight in the healthcare sector, specifically within the drug manufacturing industry, specializing in both specialty and generic medications. With a market capitalization of..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unlocking a Promising 27.88% Upside

GE HealthCare Technologies Inc. (NYSE: GEHC) stands at the forefront of the medical device industry, offering a compelling investment opportunity with a potential upside of 27.88%, according to analyst projections...

Eli Lilly and Company (LLY) Stock Analysis: Evaluating a Pharmaceutical Giant with a 9.96% Upside Potential

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, particularly in the field of general drug manufacturing, has been capturing investor attention with its robust financial performance..

Search

Funds

June 1, 2026

Search

Funds

June 1, 2026

FTSE 100

Funds